CD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis

Leukemia Research

Volumn 39, Issue 7, 2015, Pages 749-756

  Galli, Serena ^a,b   Zlobec, Inti ^a   Schürch, Christian ^a,c   Perren, Aurel ^a   Ochsenbein, Adrian F ^b,c   Banz, Yara ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute myeloid leukemia; Bone marrow; CD47; Tissue microarray

Indexed keywords

CD47 ANTIGEN; NUCLEOPHOSMIN; CD47 PROTEIN, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NPM1 GENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; TISSUE MICROARRAY; VERY ELDERLY; METABOLISM; PATHOLOGY;

ANTIGENS, CD47; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID, ACUTE; PROGNOSIS; TISSUE ARRAY ANALYSIS;

EID: 84930382862     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2015.04.007     Document Type: Article

References (18)

1. Oldenborg P.A., Gresham H.D., Lindberg F.P. CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med 2001, 193:855-862.
2. Roberts D.D., Miller T.W., Rogers N.M., Yao M., Isenberg J.S. The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47. Matrix Biol 2012, 31:162-169.
3. Cooper D., Lindberg F.P., Gamble J.R., Brown E.J., Vadas M.A. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci U S A 1995, 92:3978-3982.
4. Jaiswal S., Jamieson C.H., Pang W.W., Park C.Y., Chao M.P., Majeti R., et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 2009, 138:271-285.
5. Majeti R., Chao M.P., Alizadeh A.A. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell 2009, 138:286-299.
6. Jiang H., Fu R., Wang H., Li L., Liu H., Shao Z. CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome. Leuk Res 2013, 37:907-910.
7. Braun D., Galibert L., Nakajima T., Saito H., Quang V.V., Rubio M., et al. Semimature stage: a checkpoint in a dendritic cell maturation program that allows for functional reversion after signal-regulatory protein-alpha ligation and maturation signals. J Immunol 2006, 177:8550-8559.
8. Irandoust M., Alvarez Zarate J., Hubeek I., van Beek E.M., Schomagel K., Broekhuizen A.J., et al. Engagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells. PLOS ONE 2013, 8:e52143.
9. Majeti R. Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells. Oncogene 2011, 30:1009-1019.
10. Martin-Padura I., Marighetti P., Gregato G., Agliano A., Malazzi O., Mancuso P., et al. Spontaneous cell fusion of acute leukemia cells and macrophages observed in cells with leukemic potential. Neoplasia 2012, 14:1057-1066.
11. Theocharides A.P., Jin L., Cheng P.Y., Prasolava T.K., Maiko A.V., Ho J.M., et al. Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. J Exp Med 2012, 209:1883-1899.
12. Kishi K., Toba K., Azegami T., Tsukada N., Uesugi Y., Masuko M., et al. Hematopoietic cytokine-dependent differentiation to eosinophils and neutrophils in a newly established acute promyelocytic leukemia cell line with t(15;17). Exp Hematol 1998, 26:135-142.
13. Sundstrom C., Nilsson K. Establishment and characterization of a human histiocyte cell line (U937). Int J Cancer 1976, 17:565-577.
14. WHO classification of tumours of the haematopoietic and lymphoid tissue 2008, 262-264. IARC Press, Lyon, France, World Health Organization Classification of Tumours. 4th ed. S.H. Swerdlow, E. Campo, N.L. Harris (Eds.).
15. Baer M.R., Stewart C.C., Dodge R.K., Leget G., Sulé N., Mrozek K., et al. High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361). Blood 2001, 97:3574-3580.
16. Pang W.W., Pluvinage J.V., Price E.A., Sridhar K., Arber D.A., Greenberg P.L., et al. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proc Natl Acad Sci U S A 2013, 110:3011-3016.
17. Carter B.Z., Qiu Y., Huang X., Diao L., Zhang N., Coombes K.R., et al. Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood 2012, 120:173-180.
18. Buob D., Fauvel H., Buisine M.P., Truant S., Marlette C., Porchet N., et al. The complex intratumoral heterogeneity of colon cancer highlighted by laser microdissection. Dig Dis Sci 2012, 57:1271-1280.